{"url_path":"/sec/lsta/8-k/2026-07-17/cover-page","section_key":"cover-page","section_title":"Cover Page","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-07-17","source_url":"https://www.sec.gov/Archives/edgar/data/320017/0001140361-26-028763-index.html","accession_number":"0001140361-26-028763","cik":"0000320017","ticker":"LSTA","issuer_name":"LISATA THERAPEUTICS, INC.","edgar_url":"https://www.sec.gov/Archives/edgar/data/320017/0001140361-26-028763-index.html","primary_entity_key":"0000320017","primary_entity_name":"LISATA THERAPEUTICS, INC."},"word_count":308,"has_tables":true,"body_markdown":"false0000320017NASDAQ00003200172026-07-162026-07-16\n\nUNITED STATES\n\nSECURITIES AND EXCHANGE COMMISSION\n\nWashington, D.C. 20549\n\nFORM 8-K\n\nCURRENT REPORT\n\nPursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934\n\nJuly 16, 2026\n\nDate of Report (date of earliest event reported)\n\nLISATA THERAPEUTICS, INC.\n\n(Exact name of registrant as specified in its charter)\n\nDelaware\n\n001-33650\n\n22-2343568\n\n(State or other jurisdiction of incorporation or organization)\n\n(Commission File Number)\n\n(I.R.S. Employer Identification No.)\n\nP.O. Box 173 Liberty Corner, NJ 07938\n\n(Address of Principal Executive Offices)(ZipCode)\n\n(908) 842-0100\n\nRegistrant's telephone number, including area code\n\nNot Applicable\n\n(Former name or former address, if changed since last report)\n\nCheck the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the\nfollowing provisions (see General Instruction A.2. below):\n\n☐\n\nWritten communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)\n\n☐\n\nSoliciting material pursuant to Rule 14a-12 under the\nExchange Act (17 CFR 240.14a-12)\n\n☐\n\nPre-commencement communications pursuant to Rule 14d-2(b)\nunder the Exchange Act (17 CFR 240.14d-2(b))\n\n☐\n\nPre-commencement communications pursuant to Rule 13e-4(c)\nunder the Exchange Act (17 CFR 240.13e-4(c))\n\nSecurities registered pursuant to Section 12(b) of the Act:\n\nTitle of each class\n\nTrading Symbol(s)\n\nName of each exchange on which\n\nregistered\n\nCommon Stock, par value $0.001 per share\n\nLSTA\n\nThe Nasdaq Capital Market\n\nIndicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this\nchapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).\n\n☐ Emerging growth company\n\n☐ If an emerging growth company, indicate by check\nmark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act."}